Misplaced Pages

This is an old revision of this page, as edited by Yobol (talk | contribs) at 19:50, 29 August 2010 (clarify as WP:Controversy was demoted to essay from guideline). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Here are some tasks awaiting attention: Cleanup : Scientific publications -- weak Gone --SV Resolution(Talk) 15:29, 30 April 2009 (UTC) Alleged conflict of intrerest prior to 1996 -- should this be merged into discussion of approval? Expand : Why the US approval process caused controversy Charges of COI in DOJ handling of FDA's Fraud allegations against Searle. Charges of COI in hirings of 6 FDA personnel (described in GAO 86 report to Metzenbaum) Studies by Olney and others dismissed. Expand and integrate the timeline in the article Charges of COI when new FDA commissioner overturned unanimous decision of PBOI Senator Metzenbaum's role in returning the controversy to the news. Why the Ramazzinni studies contribute to the controversy Allegations of COI in industry-funded critiques of Soffritti studies ... NPOV : Remember that parts of this article that deal with medical safety follow WP:MEDRS and should rely on secondary sources and must reflect the preponderance of medical opinion, while other parts of this article that deal with historical, social, legal, etc. aspects explain the controversy should rely on secondary sources as much as possible but are not subject to WP:MEDRS. Verify : Different types of sources are appropriate to different sections of this article.